FINDING NEW INHIBITORS FOR EML4-ALK FUSION PROTEIN: A COMPUTATIONAL APPROACH
Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2012, Vol 3, Issue 3
Abstract
The fusion between echinoderm microtubule-associated protein-like 4 (EML4) and anaplastic lymphoma kinase (ALK) has recently been identified in a subset of non-small cell lung cancers (NSCLC). PF-02341066 (crizotinib) is an orally bioavailable ALK inhibitor currently under clinical development. PF-02341066 in EML4-ALK NSCLC was designed for patients not eligible for the phase III trial or patients randomized to chemotherapy who subsequently developed progressive disease. PF-02341066 is a dual inhibitor of mesenchymal epithelial transition growth factor (c-met) and anaplastic lymphoma kinase translocation gene and caused tumour shrinkage in 52% of patients in a phase I study. However, some studies also show denovo mutations within the kinase domain of EML4-ALK that confers resistance to multiple ALK inhibitors. Hence development of new inhibitors with better binding affinities towards the EML4-ALK is the need of the hour for subsequent clinical validation. Computational (virtual) screening of drug-like compounds against the protein targets like EML4-ALK, might help to identify specific lead inhibitors more efficiently. The Protein- Ligand interaction plays a significant role in structure based drug designing. In the current study, we have considered EML4-ALK, a fusion protein involved in NSCLCs as a receptor and NCI subset Ligands as drugs. The receptor was docked to the NCI database of drugs and a docking score was calculated using GLIDE docking software. Based on the docking score, we choose the best drugs and analyzed its ADME properties using Qikprop tool. The results of this analysis show some novel compounds that can be further evaluated as EML4-ALK inhibitors in experimental NSCLC cell lines. The study further supports the application of computer-aided techniques to the discovery of novel and specific drug for EML4-ALK fusion protein.
Authors and Affiliations
Sabitha Kesavan , Vijayalakshmi Ramshankar
Keywords
Related Articles
- EP ID EP145567
- DOI -
- Views 114
- Downloads 0
ANTIMICROBIAL ACTIVITY OF SESBANIA GRANDIFLORA (L.) PERS .
Sesbania grandiflora (L.) Pers is a plant that is used in traditional medicine for the treatment of cold,fever, stomach disorder, diarrhea and jaundice and as skin cleanser. To evaluate the scientific basis for the use o...
STANDARDIZATION OF SAPTAMRUTA LOHA
Ras-shastra is a science of metal, minerals, as well as herbomineral preparations. Standardization of herbomineral drug is today’s burning issue due to its complexity. So multi dimensional approach is essential for stand...
IN VIVO EVALUATION OF HYPOGLYCEMIC ACTIVITY OF SOLID DISPERSIONS OF GLIBENCLAMIDE USING PREGELATINISED STARCH AS A SOLUBILITY ENHANCER
Current study was undertaken to investigate the aptness of pregelatinised starch to get better solubility and In vitro dissolution rate of the poorly water soluble drug glibenclamide. Physical mixtures, kneading mixtures...
IN VITRO ANTIRHEUMATOID ARTHRITIC ACTIVITY OF AQUEOUS ROOT EXTRACT OF CLITORIA TERNATEA
In ethano medicine, roots of Clitoria ternatea (Family: Fabaceae) is claimed to possess antirheumatoid arthritic activity. However, this claim has not been scientifically tested and validated yet. This study assessed the...
NOVEL 3-ACETYLCOUMARIN SCHIFF’S BASE SYNTHESIS FROM DIFFERENT ACID HYDRAZIDE
A new series of Schiff’s bases, SB1, SB2 and SB3 were synthesized from 3-acetylcoumarin and different acid hydrazides. The 3-acetyl coumarin was synthesized starting from salicylaldehyde and ethylacetoacetate. The struct...